The role of macrophages in hepatocellular carcinoma and their therapeutic potential
Bannister, Megan E Chatterjee, Devnandan A Shetty, Shishir Patten, Daniel A
Bannister, Megan E
Chatterjee, Devnandan A
Shetty, Shishir
Patten, Daniel A
Abstract
Hepatocellular carcinoma (HCC) represents a significant clinical burden globally and is predicted to continue to increase in incidence for the foreseeable future. The treatment of HCC is complicated by the fact that, in the majority of cases, it develops on a background of advanced chronic inflammatory liver disease. Chronic inflammation can foster an immunosuppressive microenvironment that promotes tumour progression and metastasis. In this setting, macrophages make up a major immune component of the HCC tumour microenvironment, and in this review, we focus on their contribution to HCC development and progression. Tumour-associated macrophages (TAMs) are largely derived from infiltrating monocytes and their potent anti-inflammatory phenotype can be induced by factors that are found within the tumour microenvironment, such as growth factors, cytokines, hypoxia, and extracellular matrix (ECM) proteins. In general, experimental evidence suggest that TAMs can exhibit a variety of functions that aid HCC tumour progression, including the promotion of angiogenesis, resistance to drug therapy, and releasing factors that support tumour cell proliferation and metastasis. Despite their tumour-promoting profile, there is evidence that the underlying plasticity of these cells can be targeted to help reprogramme TAMs to drive tumour-specific immune responses. We discuss the potential for targeting TAMs therapeutically either by altering their phenotype within the HCC microenvironment or by cell therapy approaches by taking advantage of their infiltrative properties from the circulation into tumour tissue.
MIDER Authors
Date
2024-12-07
Type
Article
Subject
Oncology. Pathology., Gastroenterology
Collections
Citation
Bannister ME, Chatterjee DA, Shetty S, Patten DA. The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential. Int J Mol Sci. 2024 Dec 7;25(23):13167. doi: 10.3390/ijms252313167.
Journal / Source Title
International Journal of Molecular Sciences
DOI
10.3390/ijms252313167
PMID
39684877
Publisher
MDPI
Publisher’s URL
http://www.mdpi.com/journal/ijms